N-Acetyl-L-ornithine
CAS No. 6205-08-9
N-Acetyl-L-ornithine( N-Acetylornithine | Acetyl-ornithine )
Catalog No. M19991 CAS No. 6205-08-9
N-Acetylornithine is a minor component of deproteinized blood plasma of human blood. Human blood plasma contains a variable amount of acetylornithine averaging 1.1 +/- 0.4 μmol/L.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | 43 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Acetyl-L-ornithine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Acetylornithine is a minor component of deproteinized blood plasma of human blood. Human blood plasma contains a variable amount of acetylornithine averaging 1.1 +/- 0.4 μmol/L.
-
DescriptionN-Acetylornithine is a minor component of deproteinized blood plasma of human blood. Human blood plasma contains a variable amount of acetylornithine averaging 1.1 +/- 0.4 μmol/L. Urine contains a very small amount of acetylornithine approximately 1 nmol/mg creatinine (1 μmol/day).
-
In Vitro——
-
In Vivo——
-
SynonymsN-Acetylornithine | Acetyl-ornithine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6205-08-9
-
Formula Weight174.2
-
Molecular FormulaC7H14N2O3
-
Purity>98% (HPLC)
-
SolubilityWater:97.6 mM
-
SMILESCC(=O)N[C@@H](CCCN)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sreekumar A et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
molnova catalog
related products
-
3',4',7-Trimethoxyqu...
3',4',7-Trimethoxyquercetin is a polymethoxyquercetin isolated from Scutellaria baicalensis with antioxidant activity.
-
Bucetin
Bucetin is a pharmaceutical drug that acts as an analgesic and antipyretic.
-
Oxindole
Oxindole is an aromatic heterocyclic building block.?2-indolinone derivatives have become lead compounds in the research of kinase inhibitors.Oxindole structure has been used in receptor tyrosine kinases (RTKs) inhibitors such as SU4984 and intedanib, the RTK family represents an important therapeutic target for anti-cancer drug development.